Drug	ATC_ClassID	ATC_ClassName	EPC_ClassID	EPC_ClassName	MOA_ClassID	MOA_ClassName
Goserelin Acetate	L02AE	Gonadotropin releasing hormone analogues	null	null	null	null
Venetoclax	null	null	null	null	null	null
Abiraterone Acetate	L02BX	Other hormone antagonists and related agents	N0000182633	Cytochrome P450 17A1 Inhibitor	N0000187062	Cytochrome P450 2C8 Inhibitors
Idelalisib	L01XX	Other antineoplastic agents	N0000175605	Kinase Inhibitor	N0000190114	Cytochrome P450 3A Inhibitors
Carfilzomib	L01XX	Other antineoplastic agents	N0000175604	Proteasome Inhibitor	N0000175075	Proteasome Inhibitors
Pamidronate Disodium	null	null	N0000175579	Bisphosphonate	null	null
Idarubicin Hydrochloride	L01DB	Anthracyclines and related substances	N0000175414	Anthracycline Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Temsirolimus	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Axitinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000020000	Receptor Tyrosine Kinase Inhibitors
Crizotinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000191265	Organic Cation Transporter 1 Inhibitors
Ondansetron Hydrochloride	A04AA	Serotonin (5HT3) antagonists	N0000175818	Serotonin-3 Receptor Antagonist	N0000175817	Serotonin 3 Receptor Antagonists
Carmustine	L01AD	Nitrosoureas	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Ziv-Aflibercept	S01LA	Antineovascularisation agents	null	null	null	null
Talc	null	null	null	null	null	null
Megestrol Acetate	L02AB	Progestogens	N0000175602	Progestin	null	null
Melphalan	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Ixazomib Citrate	L01XX	Other antineoplastic agents	N0000175604	Proteasome Inhibitor	N0000175075	Proteasome Inhibitors
Docetaxel	L01CD	Taxanes	N0000175592	Microtubule Inhibitor	null	null
Trametinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Aminolevulinic Acid	L01XD	Sensitizers used in photodynamic/radiation therapy	N0000175846	Porphyrin Precursor	null	null
Ifosfamide	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Palifermin	V03AF	Detoxifying agents for antineoplastic treatment	N0000175671	Mucocutaneous Epithelial Cell Growth Factor	null	null
Ipilimumab	L01XC	Monoclonal antibodies	N0000182635	CTLA-4-directed Blocking Antibody	N0000182634	CTLA-4-directed Antibody Interactions
Blinatumomab	L01XC	Monoclonal antibodies	N0000191421	Bispecific CD19-directed CD3-directed T Cell Engager	N0000191422	CD19-directed Antibody Interactions
Bevacizumab	L01XC	Monoclonal antibodies	N0000178292	Vascular Endothelial Growth Factor-directed Antibody	N0000178291	Vascular Endothelial Growth Factor-directed Antibody Interactions
Bexarotene	L01XX	Other antineoplastic agents	N0000175607	Retinoid	null	null
Flutamide	L02BB	Anti-androgens	N0000175560	Androgen Receptor Inhibitor	N0000000243	Androgen Receptor Antagonists
Pazopanib Hydrochloride	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000187062	Cytochrome P450 2C8 Inhibitors
Gemcitabine Hydrochloride	L01BC	Pyrimidine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Oxaliplatin	L01XA	Platinum compounds	N0000175413	Platinum-based Drug	null	null
Lanreotide Acetate	H01CB	Somatostatin and analogues	N0000175904	Somatostatin Analog	N0000000194	Somatostatin Receptor Agonists
Romidepsin	L01XX	Other antineoplastic agents	N0000175588	Histone Deacetylase Inhibitor	N0000175071	Histone Deacetylase Inhibitors
Dexrazoxane Hydrochloride	V03AF	Detoxifying agents for antineoplastic treatment	N0000180854	Cytoprotective Agent	null	null
Epirubicin Hydrochloride	L01DB	Anthracyclines and related substances	N0000175414	Anthracycline Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Raloxifene Hydrochloride	G03XC	Selective estrogen receptor modulators	N0000175826	Estrogen Agonist/Antagonist	N0000000168	Selective Estrogen Receptor Modulators
Ibrutinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Exemestane	L02BG	Aromatase inhibitors	N0000175563	Aromatase Inhibitor	N0000175080	Aromatase Inhibitors
Pegaspargase	L01XX	Other antineoplastic agents	N0000175669	Asparagine-specific Enzyme	null	null
Etoposide	L01CB	Podophyllotoxin derivatives	N0000175609	Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Mesna	V03AF	Detoxifying agents for antineoplastic treatment	null	null	null	null
Lomustine	L01AD	Nitrosoureas	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Pomalidomide	L04AX	Other immunosuppressants	N0000184014	Thalidomide Analog	null	null
Trabectedin	L01CX	Other plant alkaloids and natural products	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Cytarabine	L01BC	Pyrimidine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Pembrolizumab	L01XC	Monoclonal antibodies	N0000191260	Programmed Death Receptor-1 Blocking Antibody	N0000191259	Programmed Death Receptor-1-directed Antibody Interactions
Sorafenib Tosylate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Plerixafor	L03AX	Other immunostimulants	N0000178326	Hematopoietic Stem Cell Mobilizer	null	null
Recombinant Human Papillomavirus (HPV) Bivalent Vaccine	null	null	null	null	null	null
Panitumumab	L01XC	Monoclonal antibodies	N0000175664	Epidermal Growth Factor Receptor Antagonist	N0000020010	HER1 Antagonists
Dinutuximab	L01XC	Monoclonal antibodies	null	null	null	null
Carboplatin	L01XA	Platinum compounds	N0000175413	Platinum-based Drug	null	null
Dexamethasone	S03BA	Corticosteroids	N0000175576	Corticosteroid	N0000175450	Corticosteroid Hormone Receptor Agonists
Imatinib Mesylate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Denosumab	M05BX	Other drugs affecting bone structure and mineralization	N0000187055	RANK Ligand Inhibitor	N0000187054	RANK Ligand Blocking Activity
Omacetaxine Mepesuccinate	L01XX	Other antineoplastic agents	null	null	null	null
Obinutuzumab	L01XC	Monoclonal antibodies	N0000175657	CD20-directed Cytolytic Antibody	N0000175078	CD20-directed Antibody Interactions
Chlorambucil	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Prednisone	H02AB	Glucocorticoids	N0000175576	Corticosteroid	N0000175450	Corticosteroid Hormone Receptor Agonists
Ibritumomab Tiuxetan	null	null	N0000175658	CD20-directed Radiotherapeutic Antibody	N0000175078	CD20-directed Antibody Interactions
Cetuximab	L01XC	Monoclonal antibodies	N0000175664	Epidermal Growth Factor Receptor Antagonist	N0000020010	HER1 Antagonists
Siltuximab	L04AC	Interleukin inhibitors	N0000191006	Interleukin-6 Antagonist	N0000191004	Interleukin-6 Antagonists
Decitabine	L01BC	Pyrimidine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Sipuleucel-T	L03AX	Other immunostimulants	N0000184997	Autologous Cellular Immunotherapy	null	null
Aldesleukin	L03AC	Interleukins	N0000175667	Lymphocyte Growth Factor	null	null
Cabazitaxel	L01CD	Taxanes	N0000175592	Microtubule Inhibitor	null	null
Rolapitant Hydrochloride	null	null	N0000175786	Substance P/Neurokinin-1 Receptor Antagonist	N0000190113	Breast Cancer Resistance Protein Inhibitors
Degarelix	L02BX	Other hormone antagonists and related agents	null	null	null	null
Panobinostat	L01XX	Other antineoplastic agents	N0000175588	Histone Deacetylase Inhibitor	N0000182137	Cytochrome P450 2D6 Inhibitors
Arsenic Trioxide	L01XX	Other antineoplastic agents	null	null	null	null
Osimertinib	null	null	N0000175605	Kinase Inhibitor	N0000191266	Cytochrome P450 1A2 Inducers
Nivolumab	L01XC	Monoclonal antibodies	N0000191260	Programmed Death Receptor-1 Blocking Antibody	N0000191259	Programmed Death Receptor-1-directed Antibody Interactions
Leuprolide Acetate	L02AE	Gonadotropin releasing hormone analogues	N0000175655	Gonadotropin Releasing Hormone Receptor Agonist	N0000175654	Gonadotropin Releasing Hormone Receptor Agonists
Eribulin Mesylate	L01XX	Other antineoplastic agents	N0000175592	Microtubule Inhibitor	null	null
Lenalidomide	L04AX	Other immunosuppressants	N0000184014	Thalidomide Analog	null	null
Mitoxantrone Hydrochloride	L01DB	Anthracyclines and related substances	N0000175609	Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Hydroxyurea	L01XX	Other antineoplastic agents	N0000180853	Antimetabolite	null	null
Ceritinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000190114	Cytochrome P450 3A Inhibitors
Toremifene	L02BA	Anti-estrogens	N0000175826	Estrogen Agonist/Antagonist	N0000000168	Selective Estrogen Receptor Modulators
Capecitabine	L01BC	Pyrimidine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Topotecan Hydrochloride	L01XX	Other antineoplastic agents	N0000175609	Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Vorinostat	L01XX	Other antineoplastic agents	N0000175588	Histone Deacetylase Inhibitor	N0000175071	Histone Deacetylase Inhibitors
Belinostat	L01XX	Other antineoplastic agents	N0000175588	Histone Deacetylase Inhibitor	N0000175071	Histone Deacetylase Inhibitors
Elotuzumab	null	null	N0000192338	SLAMF7-directed Immunostimulatory Antibody	N0000192337	SLAMF7-directed Antibody Interactions
Tamoxifen Citrate	L02BA	Anti-estrogens	N0000175826	Estrogen Agonist/Antagonist	N0000000168	Selective Estrogen Receptor Modulators
Rasburicase	V03AF	Detoxifying agents for antineoplastic treatment	N0000175670	Uric Acid-specific Enzyme	null	null
Lenvatinib Mesylate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000020000	Receptor Tyrosine Kinase Inhibitors
Romiplostim	B02BX	Other systemic hemostatics	N0000175973	Thrombopoietin Receptor Agonist	N0000175968	Thrombopoietin Receptor Agonists
Filgrastim	L03AA	Colony stimulating factors	N0000175666	Leukocyte Growth Factor	null	null
Talimogene Laherparepvec	null	null	null	null	null	null
Radium 223 Dichloride	null	null	null	null	null	null
Thiotepa	L01AC	Ethylene imines	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Glucarpidase	V03AF	Detoxifying agents for antineoplastic treatment	N0000184013	Carboxypeptidase	null	null
Peginterferon Alfa-2b	L03AB	Interferons	N0000175521	Interferon alpha	null	null
Fluorouracil	L01BC	Pyrimidine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Afatinib Dimaleate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Recombinant Interferon Alfa-2b	null	null	null	null	null	null
Busulfan	L01AB	Alkyl sulfonates	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Procarbazine Hydrochloride	L01XB	Methylhydrazines	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Dasatinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Letrozole	L02BG	Aromatase inhibitors	N0000175563	Aromatase Inhibitor	N0000175080	Aromatase Inhibitors
Imiquimod	D06BB	Antivirals	null	null	N0000000157	Interferon Inducers
Palbociclib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000190114	Cytochrome P450 3A Inhibitors
Leucovorin Calcium	V03AF	Detoxifying agents for antineoplastic treatment	N0000178369	Folate Analog	null	null
Uridine Triacetate	null	null	null	null	null	null
Vinblastine Sulfate	L01CA	Vinca alkaloids and analogues	N0000175612	Vinca Alkaloid	null	null
Denileukin Diftitox	L01XX	Other antineoplastic agents	null	null	null	null
Irinotecan Hydrochloride	L01XX	Other antineoplastic agents	N0000175609	Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Gemtuzumab Ozogamicin	null	null	N0000175571	CD33-directed Cytotoxin	null	null
Azacitidine	L01BC	Pyrimidine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Dactinomycin	L01DA	Actinomycines	N0000180850	Actinomycin	N0000000233	Nucleic Acid Synthesis Inhibitors
Erlotinib Hydrochloride	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Olaparib	L01XX	Other antineoplastic agents	N0000191623	Poly(ADP-Ribose) Polymerase Inhibitor	N0000191622	Poly(ADP-Ribose) Polymerase Inhibitors
Nilotinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Cabozantinib-S-Malate	null	null	null	null	null	null
Necitumumab	L01XC	Monoclonal antibodies	N0000175664	Epidermal Growth Factor Receptor Antagonist	N0000020010	HER1 Antagonists
Paclitaxel	L01CD	Taxanes	N0000175592	Microtubule Inhibitor	null	null
Daratumumab	null	null	N0000192336	CD38-directed Cytolytic Antibody	N0000192335	CD38-directed Antibody Interactions
Enzalutamide	L02BB	Anti-androgens	N0000175560	Androgen Receptor Inhibitor	N0000185607	Cytochrome P450 2C19 Inducers
Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine	null	null	null	null	null	null
Clofarabine	L01BB	Purine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Defibrotide Sodium	B01AX	Other antithrombotic agents	null	null	null	null
Fludarabine Phosphate	L01BB	Purine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Trastuzumab	L01XC	Monoclonal antibodies	N0000175661	HER2 Receptor Antagonist	N0000020008	HER2/Neu/cerbB2 Antagonists
Ado-Trastuzumab Emtansine	L01XC	Monoclonal antibodies	null	null	null	null
Vemurafenib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000185503	P-Glycoprotein Inhibitors
Vismodegib	L01XX	Other antineoplastic agents	N0000184149	Hedgehog Pathway Inhibitor	N0000184148	Smoothened Receptor Antagonists
Everolimus	L04AA	Selective immunosuppressants	N0000175605	Kinase Inhibitor	N0000185503	P-Glycoprotein Inhibitors
Bortezomib	L01XX	Other antineoplastic agents	N0000175604	Proteasome Inhibitor	N0000175075	Proteasome Inhibitors
Thalidomide	L04AX	Other immunosuppressants	null	null	null	null
Temozolomide	L01AX	Other alkylating agents	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Pertuzumab	L01XC	Monoclonal antibodies	N0000175661	HER2 Receptor Antagonist	N0000020008	HER2/Neu/cerbB2 Antagonists
Brentuximab Vedotin	L01XC	Monoclonal antibodies	N0000182967	CD30-directed Immunoconjugate	N0000182966	CD30-directed Antibody Interactions
Dacarbazine	L01AX	Other alkylating agents	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Ofatumumab	L01XC	Monoclonal antibodies	N0000175657	CD20-directed Cytolytic Antibody	N0000175078	CD20-directed Antibody Interactions
Pemetrexed Disodium	L01BA	Folic acid analogues	N0000175584	Folate Analog Metabolic Inhibitor	N0000000111	Folic Acid Metabolism Inhibitors
Dabrafenib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000190113	Breast Cancer Resistance Protein Inhibitors
Eltrombopag Olamine	B02BX	Other systemic hemostatics	N0000175973	Thrombopoietin Receptor Agonist	N0000191278	UGT1A9 Inhibitors
Fulvestrant	L02BA	Anti-estrogens	N0000175582	Estrogen Receptor Antagonist	N0000000168	Selective Estrogen Receptor Modulators
Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine	null	null	null	null	null	null
Rituximab	L01XC	Monoclonal antibodies	N0000175657	CD20-directed Cytolytic Antibody	N0000175078	CD20-directed Antibody Interactions
Thioguanine	L01BB	Purine analogues	N0000180853	Antimetabolite	null	null
Regorafenib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000185504	Cytochrome P450 2C9 Inhibitors
Anastrozole	L02BG	Aromatase inhibitors	N0000175563	Aromatase Inhibitor	N0000175080	Aromatase Inhibitors
Bicalutamide	L02BB	Anti-androgens	N0000175560	Androgen Receptor Inhibitor	N0000000243	Androgen Receptor Antagonists
Melphalan Hydrochloride	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Gefitinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Asparaginase Erwinia chrysanthemi	null	null	null	null	null	null
Aprepitant	A04AD	Other antiemetics	N0000175786	Substance P/Neurokinin-1 Receptor Antagonist	N0000185507	Cytochrome P450 2C9 Inducers
Bendamustine Hydrochloride	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Pralatrexate	L01BA	Folic acid analogues	N0000175584	Folate Analog Metabolic Inhibitor	null	null
Sunitinib Malate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Alemtuzumab	L04AA	Selective immunosuppressants	N0000175659	CD52-directed Cytolytic Antibody	N0000175079	CD52-directed Antibody Interactions
Cyclophosphamide	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Sonidegib	L01XX	Other antineoplastic agents	N0000184149	Hedgehog Pathway Inhibitor	N0000184148	Smoothened Receptor Antagonists
Ruxolitinib Phosphate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Ponatinib Hydrochloride	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Lapatinib Ditosylate	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000175076	Protein Kinase Inhibitors
Nelarabine	L01BB	Purine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Vinorelbine Tartrate	L01CA	Vinca alkaloids and analogues	N0000175612	Vinca Alkaloid	null	null
Methotrexate	L04AX	Other immunosuppressants	N0000175584	Folate Analog Metabolic Inhibitor	N0000000111	Folic Acid Metabolism Inhibitors
Bleomycin	L01DC	Other cytotoxic antibiotics	N0000180854	Cytoprotective Agent	null	null
Cisplatin	L01XA	Platinum compounds	N0000175413	Platinum-based Drug	null	null
Mitomycin C	L01DC	Other cytotoxic antibiotics	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
Zoledronic Acid	M05BA	Bisphosphonates	N0000175579	Bisphosphonate	null	null
Doxorubicin Hydrochloride	L01DB	Anthracyclines and related substances	N0000175414	Anthracycline Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Alectinib	null	null	N0000175605	Kinase Inhibitor	N0000175082	Kinase Inhibitors
Bosutinib	L01XE	Protein kinase inhibitors	N0000175605	Kinase Inhibitor	N0000185503	P-Glycoprotein Inhibitors
Daunorubicin Hydrochloride	L01DB	Anthracyclines and related substances	N0000175414	Anthracycline Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Mercaptopurine	L01BB	Purine analogues	N0000175595	Nucleoside Metabolic Inhibitor	N0000000233	Nucleic Acid Synthesis Inhibitors
Ixabepilone	L01DC	Other cytotoxic antibiotics	N0000175592	Microtubule Inhibitor	null	null
Cobimetinib	null	null	N0000175605	Kinase Inhibitor	N0000175082	Kinase Inhibitors
Etoposide Phosphate	L01CB	Podophyllotoxin derivatives	N0000175609	Topoisomerase Inhibitor	N0000000176	Topoisomerase Inhibitors
Vincristine Sulfate	L01CA	Vinca alkaloids and analogues	N0000175612	Vinca Alkaloid	null	null
Ramucirumab	L01XC	Monoclonal antibodies	N0000191009	Vascular Endothelial Growth Factor Receptor 2 Antagonist	N0000020032	VEGFR2 Inhibitors
Palonosetron Hydrochloride	A04AA	Serotonin (5HT3) antagonists	N0000175818	Serotonin-3 Receptor Antagonist	N0000175817	Serotonin 3 Receptor Antagonists
Paclitaxel Albumin-stabilized Nanoparticle Formulation	null	null	null	null	null	null
Mechlorethamine Hydrochloride	L01AA	Nitrogen mustard analogues	N0000175558	Alkylating Drug	N0000000236	Alkylating Activity
